Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media?

OBJECTIVES: To assess the visibility of clinically significant prostate cancer (PCA) lesions on the sequences multiparametric MRI of the prostate (mpMRI) and to evaluate whether the addition of dynamic contrast–enhanced imaging (DCE) improves the overall visibility. METHODS: We retrospectively evalu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Radiol
Autors principals: Huebner, Nicolai Alexander, Korn, Stephan, Resch, Irene, Grubmüller, Bernhard, Gross, Tobias, Gale, Robert, Kramer, Gero, Poetsch, Nina, Clauser, Paola, Haitel, Andrea, Fajkovic, Harun, Shariat, Shahrokh F., Baltzer, Pascal A.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2020
Matèries:
Urogenital
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8128749/
https://ncbi.nlm.nih.gov/pubmed/33263793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00330-020-07494-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars